Walters, D. M., Lindberg, J. M., Adair, S. J., Newhook, T. E., Cowan, C. R., Stokes, J. B., . . . Bauer, T. W. (2013). Inhibition of the Growth of Patient-Derived Pancreatic Cancer Xenografts with the MEK Inhibitor Trametinib Is Augmented by Combined Treatment with the Epidermal Growth Factor Receptor/HER2 Inhibitor Lapatinib. Neoplasia Press Inc.
Style de citation ChicagoWalters, Dustin M., et al. Inhibition of the Growth of Patient-Derived Pancreatic Cancer Xenografts With the MEK Inhibitor Trametinib Is Augmented By Combined Treatment With the Epidermal Growth Factor Receptor/HER2 Inhibitor Lapatinib. Neoplasia Press Inc, 2013.
Style de citation MLAWalters, Dustin M., et al. Inhibition of the Growth of Patient-Derived Pancreatic Cancer Xenografts With the MEK Inhibitor Trametinib Is Augmented By Combined Treatment With the Epidermal Growth Factor Receptor/HER2 Inhibitor Lapatinib. Neoplasia Press Inc, 2013.